MarthaQLacyMD

PubMed

• Outcomes of patients with multiple myeloma refractory to standard dose vs low dose lenalidomide.
  Utkarsh Goel, Charalampos Charalampous, Prashant Kapoor, Moritz Binder, Francis K Buadi, David Dingli, Angela Dispenzieri, Amie Fonder, Morie A Gertz, Wilson I Gonsalv...> ;Blood Cancer Journal. 2024 Mar 26
• Academic Promotions in Medicine: An Appraisal of Fairness.
  Rahma Warsame, Yong-Hun Kim, Melody Y Ouk, Kristin C Mara, Martha Q Lacy, Sharonne N Hayes, Zamzam Shalle, Joyce Balls-Berry, Barbara L Jordan, Felicity T Enders, Alex...> ;Mayo Clinic Proceedings. 2024 Mar 1
• Phase III randomized trial of Thal+ZLD versus ZLD in patients with asymptomatic multiple myeloma - updated results after 18-year follow-up.
  Nadine Abdallah, Thomas E Witzig, Shaji K Kumar, Martha Q Lacy, Suzanne R Hayman, Angela Dispenzieri, Vivek Roy, Morie A Gertz, P Leif Bergsagel, S Vincent Rajkumar> ;Leukemia. 2024 Feb 28
• Mode of progression in smoldering multiple myeloma: a study of 406 patients.
  Abdallah, N., Lakshman, A., Kumar, S., Cook, J., Binder, M., Kapoor, P., Dispenzieri, A., Gertz, M., Lacy, M., Hayman, S., Buadi, F., Dingli, D., Lin, Y., Kourelis, T....> ;Blood Cancer Journal. 2024 Jan 17
• Muscle and fat composition in patients with newly diagnosed multiple myeloma.
  Abdallah, N., Nagayama, H., Takahashi, N., Gonsalves, W., Fonder, A., Dispenzieri, A., Dingli, D., Buadi, F., Lacy, M., Hobbs, M., Gertz, M., Binder, M., Kapoor, P., W...> ;Blood Cancer Journal. 2023 Dec 12
• Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma.
  Charalampous, C., Goel, U., Kapoor, P., Binder, M., Buadi, F., Cook, J., Dingli, D., Dispenzieri, A., Fonder, A., Gertz, M., Gonsalves, W., Hayman, S., Hobbs, M., Hwa,...> ;Blood Cancer Journal. 2023 Dec 11
• 2 citations
  Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomas.
  Udit Yadav, Shaji K Kumar, Linda B Baughn, Angela Dispenzieri, Patricia Greipp, Rhett Ketterling, Dragan Jevremovic, Francis K Buadi, David Dingli, Martha Q Lacy, Rafa...> ;Blood. 2023 Nov 30
• Predictors and Impact of Timing of Disease Progression Following Primary Therapy in Multiple Myeloma.
  Sarah Goldman-Mazur, Alissa Visram, S Vincent Rajkumar, Prashant Kapoor, Angela Dispenzieri, Martha Q Lacy, Morie A Gertz, Francis K Buadi, Suzanne R Hayman, David Din...> ;Clinical Lymphoma, Myeloma & Leukemia. 2024 Mar 1
• Outcomes of patients with primary refractory multiple myeloma in the era of triplet and quadruplet induction therapy.
  Charalampos Charalampous, Utkarsh Goel, Prashant Kapoor, Moritz Binder, Francis K Buadi, Joselle Cook, David Dingli, Angela Dispenzieri, Amie L Fonder, Morie A Gertz, ...> ;Blood Advances. 2023 Aug 22
• Outcomes of patients with primary refractory multiple myeloma in the era of triplet and quadruplet induction therapy.
  Charalampos Charalampous, Utkarsh Goel, Prashant Kapoor, Moritz Binder, Francis K Buadi, Joselle Cook, David Dingli, Angela Dispenzieri, Amie L Fonder, Morie A Gertz, ...> ;Blood Advances. 2023 Aug 22
• 1 citations
  Long-term outcomes of allogeneic stem cell transplant in multiple myeloma.
  Walker M Schmidt, Nirosha D Perera, Francis K Buadi, Suzanne R Hayman, Shaji K Kumar, Angela Dispenzieri, David Dingli, Joselle Cook, Martha Q Lacy, Prashant Kapoor, N...> ;Blood Cancer Journal. 2023 Aug 18
• 5 citations
  Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myeloma.
  Saurabh Zanwar, Matthew Ho, Yi Lin, Prashant Kapoor, Moritz Binder, Francis K Buadi, Angela Dispenzieri, David Dingli, Amie Fonder, Morie A Gertz, Wilson Gonsalves, Su...> ;American Journal of Hematology. 2023 Oct 1
• A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (CARAMEL).
  Alissa Visram, Suzanne R Hayman, Angela Dispenzieri, Prashant Kapoor, Martha Q Lacy, Morie A Gertz, Francis K Buadi, David Dingli, Rahma Warsame, Taxiarchis Kourelis, ...> ;American Journal of Hematology. 2023 Aug 1
• 1 citations
  Conditional survival in multiple myeloma and impact of prognostic factors over time.
  Nadine H Abdallah, Alexandra N Smith, Susan Geyer, Moritz Binder, Patricia T Greipp, Prashant Kapoor, Angela Dispenzieri, Morie A Gertz, Linda B Baughn, Martha Q Lacy,...> ;Blood Cancer Journal. 2023 May 15
• 5 citations
  Defining drug/drug class refractoriness vs lines of therapy in relapsed/refractory multiple myeloma.
  Utkarsh Goel, Charalampos Charalampous, Prashant Kapoor, Moritz Binder, Francis K Buadi, David Dingli, Angela Dispenzieri, Amie Fonder, Morie A Gertz, Wilson I Gonsalv...> ;Blood Cancer Journal. 2023 Jan 11
• 4 citations
  Survival trends in young patients with Waldenström macroglobulinemia: Over five decades of experience.
  Karan L Chohan, Jonas Paludo, Nishanth Vallumsetla, Dirk Larson, Rebecca L King, Rong He, Wilson Gonsalves, David Inwards, Thomas E Witzig, Abhisek Swaika, Tania Jain,...> ;American Journal of Hematology. 2023 Mar 1
• 4 citations
  Thrombosis in multiple myeloma: Risk estimation by induction regimen and association with overall survival.
  Charalampos Charalampous, Utkarsh Goel, Prashant Kapoor, Moritz Binder, Francis K Buadi, David Dingli, Angela Dispenzieri, Amie L Fonder, Morie A Gertz, Wilson Gonsalv...> ;American Journal of Hematology. 2023 Mar 1
• The impact of Post-Transplant doxycycline in AL amyloidosis - updated results after Long-Term follow up.
  Nadine Abdallah, Angela Dispenzieri, Eli Muchtar, Francis K Buadi, Prashant Kapoor, Martha Q Lacy, Yi L Hwa, Amie Fonder, Miriam A Hobbs, Suzanne R Hayman, Nelson Leun...> ;Amyloid. 2023 Sep 1
• 3 citations
  Value of bone marrow examination in determining response to therapy in patients with multiple myeloma in the context of mass spectrometry-based M-protein assessment.
  Jean-Sébastien Claveau, David L Murray, Angela Dispenzieri, Prashant Kapoor, Moritz Binder, Francis Buadi, David Dingli, Amie Fonder, Morie Gertz, Wilson Gonsalves, Su...> ;Leukemia. 2023 Jan 1
• 1 citations
  Second- and third-line treatment strategies in multiple myeloma: a referral-center experience.
  Sarah Goldman-Mazur, Alissa Visram, S Vincent Rajkumar, Prashant Kapoor, Angela Dispenzieri, Martha Q Lacy, Morie A Gertz, Francis K Buadi, Suzanne R Hayman, David Din...> ;Blood Cancer Journal. 2022 Dec 6
• Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathy.
  Saurabh Zanwar, Matthew Ho, Francis K Buadi, Sikander Ailawadhi, Jeremy Larsen, Leif Bergsagel, Moritz Binder, Asher Chanan-Khan, David Dingli, Angela Dispenzieri, Raf...> ;Blood Cancer Journal. 2022 Nov 24
• 3 citations
  Sarcopenia identified by computed tomography imaging using a deep learning-based segmentation approach impacts survival in patients with newly diagnosed multiple myeloma.
  Bharat Nandakumar, Francis Baffour, Nadine H Abdallah, Shaji K Kumar, Angela Dispenzieri, Francis K Buadi, David Dingli, Martha Q Lacy, Suzanne R Hayman, Prashant Kapo...> ;Cancer. 2023 Feb 1
• 15 citations
  Risk factors for severe infection and mortality In patients with COVID-19 in patients with multiple myeloma and AL amyloidosis.
  Matthew Ho, Saurabh Zanwar, Francis K Buadi, Sikander Ailawadhi, Jeremy Larsen, Leif Bergsagel, Moritz Binder, Asher Chanan-Khan, David Dingli, Angela Dispenzieri, Raf...> ;American Journal of Hematology. 2023 Jan 1
• 1 citations
  Impact of the time interval between end of induction and autologous hematopoietic transplantation in newly diagnosed patients with multiple myeloma.
  Charalampos Charalampous, Utkarsh Goel, Morie Gertz, Martha Lacy, Angela Dispenzieri, Suzanne Hayman, David Dingli, Francis Buadi, Prashant Kapoor, Taxiarchis Kourelis...> ;Bone Marrow Transplantation. 2023 Jan 1
• 2 citations
  Risk factors for severe infection and mortality in COVID-19 and monoclonal gammopathy of undetermined significance.
  Matthew Ho, Saurabh Zanwar, Francis K Buadi, Sikander Ailawadhi, Jeremy Larsen, Leif Bergsagel, Moritz Binder, Asher Chanan-Khan, David Dingli, Angela Dispenzieri, Raf...> ;Blood. 2022 Nov 3
• Join now to see all

Journal Articles

• Impact of Prior Diagnosis of Monoclonal Gammopathy on Outcomes in Newly Diagnosed Multiple Myeloma  
  S Vincent Rajkumar, Yi L Hwa, Wilson I Gonsalves, Francis K Buadi, Angela Dispenzieri, Prashant Kapoor, Miriam A Hobbs, Martha Q Lacy, John A Lust, Robert A Kyle, Mori..., Nature
• Safety and Efficacy of Propylene Glycol-Free Melphalan as Conditioning in Patients with AL Amyloidosis Undergoing Stem Cell Transplantation  
  Nelson Leung, Prashant Kapoor, Taxiarchis V Kourelis, Eli Muchtar, Angela Dispenzieri, M Hasib Sidiqi, Martha Q Lacy, Wilson I Gonsalves, Shaji K Kumar, Mohammed A Alj..., Nature
• Relapse After Complete Response in Newly Diagnosed Multiple Myeloma: Implications of Duration of Response and Patterns of Relapse  
  Angela Dispenzieri, Francis K Buadi, Morie A Gertz, Martha Q Lacy, Nelson Leung, Amie L Fonder, Wilson I Gonsalves, Yi Lisa Hwa, Taxiarchis Kourelis, Surbhi Sidana, Ro..., Nature
• Primary Systemic Amyloidosis in Patients with Waldenström Macroglobulinemia  
  Angela Dispenzieri, Eli Muchtar, Ronald Go, Saurabh Zanwar, Surbhi Sidana, Francis Buadi, Stephen M Ansell, Prashant Kapoor, David Dingli, Thomas Habermann, Shaji Kuma..., Nature
• Daratumumab-Based Therapy in Patients with Heavily-Pretreated AL Amyloidosis  
  Saurabh Zanwar, Angela Dispenzieri, Wilson Gonsalves, David Dingli, Jithma P Abeykoon, Martha Q Lacy, Shaji Kumar, Nelson Leung, Morie A Gertz, Eli Muchtar, Francis Bu..., Nature
• Optimizing Deep Response Assessment for AL Amyloidosis Using Involved Free Light Chain Level at End of Therapy: Failure of the Serum Free Light Chain Ratio  
  Morie A Gertz, David Dingli, Miriam Hobbs, John A Lust, Ronald S Go, Amie Fonder, Yi Lin, Shaji K Kumar, Prashant Kapoor, Taxiarchis V Kourelis, S Vincent Rajkumar, Ro..., Nature
• Comparable Outcomes Using Propylene Glycol-Free Melphalan for Autologous Stem Cell Transplantation in Multiple Myeloma  
  Morie A Gertz, Shaji K Kumar, Martha Q Lacy, Prashant Kapoor, Suzanne R Hayman, Robert C Wolf, William J Hogan, Wilson I Gonsalves, Angela A Dispenzieri, David Dingli,..., Nature
• Utilization of Hematopoietic Stem Cell Transplantation for the Treatment of Multiple Myeloma: A Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consen...  
  John A Lust, Shaji K Kumar, Morie A Gertz, P Leif Bergsagel, Angela Dispenzieri, Francis K Buadi, Prashant Kapoor, Angela A Mayo, Wilson I Gonsalves, Rafael Fonseca, R..., Nature
• Join now to see all

Abstracts/Posters

• Delayed Neutrophil Engraftment in Patients Receiving Daratumumab As Part of Their First Induction Regimen for Multiple Myeloma
  Martha Q. Lacy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Waldenstr_m Macroglobulinemia with Excess Plasma Cells: Is It a Distinct Entity?
  Martha Q. Lacy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• The Impact of Socioeconomic Risk Factors on the Survival Outcomes of Patients with Newly Diagnosed Multiple Myeloma
  Martha Q. Lacy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Metaphase Cytogenetics for Risk Stratification in Newly Diagnosed Multiple Myeloma
  Martha Q. Lacy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Gene Expression Profiling of Structural and Functional High-Risk Multiple Myeloma
  Martha Q. Lacy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Phase 2 Trial of Daratumumab, Ixazomib, Lenalidomide and Modified Dose Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma
  Martha Q. Lacy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Utilizing Multiparametric Flow Cytometry to Identify Patients with Primary Plasma Cell Leukemia at Diagnosis
  Martha Q. Lacy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Use of Maintenance Therapy Post Autologous Stem Cell Transplantation Outside of Clinical Trial Setting for Multiple Myeloma: Single Institution Experience
  Martha Q. Lacy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• A Novel Approach to Risk Stratification in Multiple Myeloma Using ISS Stage and FISH
  Martha Q. Lacy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• A Prospective Pilot Study of Ixazomib, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed or Relapsed/Refractory POEMS Syndrome
  Martha Q. Lacy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Mortality of Patients with Multiple Myeloma after the Introduction of Novel Therapies in the United States
  Martha Q. Lacy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Prognostic Implications of Serum Monoclonal Protein Positivity By Mass-Fix in Bone Marrow Minimal Residual Disease Negative (MRD-) Patients with Multiple Myeloma
  Martha Q. Lacy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Impact of sFLC Ratio on Outcome in Patients with MM: Validating the Utility of sFLC in Response Definition
  Martha Q. Lacy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• The Impact of Socioeconomic Risk Factors on the Survival Outcomes of Patients with Newly Diagnosed Multiple Myeloma
  Martha Q. Lacy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Optimal Therapy for Relapsed AL Amyloidosis Post Autologous Stem Cell Transplant
  Martha Q. Lacy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Join now to see all

Lectures

• Ibrutinib Therapy in Patients with Waldenstrom Macroglobulinemia: Outcomes Outside of Clinical Trial Setting 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Long-Term Survivorship with Active Multiple Myeloma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Development of Thrombocytopenia and Survival Outcomes in Newly Diagnosed Multiple Myeloma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Development of a Hematology-Specific Fellowship Curriculum for Advanced Practice Providers Utilizing a Needs-Based Assessment 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Bortezomib, Lenalidomide and Dexamethasone (VRD) Followed By Autologous Stem Cell Transplant for Newly Diagnosed Multiple Myeloma; The Mayo Clinic Experience 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Join now to see all